社区暴发中儿童麻疹的临床表现、住院情况及疫苗接种状态
研究对2018年6月至2019年5月耶路撒冷地区2254例麻疹通报病例中18岁以下儿童进行横断面分析,发现1-17岁儿童88%未接种疫苗,接种1剂疫苗儿童临床症状比例和住院风险较低(OR=4.8,95%CI 1.12-20.2),1剂疫苗对住院的疫苗有效性估计为79%。
要点
- 18岁以下儿童占麻疹通报病例的79%(1782/2254),住院率6.6%,有1例死亡。
- 1-17岁儿童中88%未接种麻疹疫苗,138例接种1剂,24例接种2剂。
- 接种1剂疫苗儿童较未接种者临床症状比例和住院风险更低(OR=4.8,95%CI 1.12-20.2)。
核心结论
- 在暴发情境下评估麻疹疫苗真实世界有效性,显示接种1剂疫苗的儿童发病率降低。
研究设计与样本
- 横断面研究,纳入2018年6月至2019年5月耶路撒冷地区居住的18岁以下麻疹病例(2254例通报病例)。
- 分析变量包括临床症状(发热、皮疹、咳嗽、卡他症状、结膜炎)、住院情况和儿童疫苗接种状态。
- 全国麻疹疫苗接种程序包括2剂次(12月龄和6岁各1剂)。
主要发现
- 18岁以下儿童占通报麻疹病例的79%(1782/2254)。
- 住院率为6.6%,有1例死亡。
- 1-17岁儿童中88%未接种疫苗,138例接种1剂麻疹疫苗,24例接种2剂。
- 1-5岁儿童中106例(13.5%)接种1剂疫苗,与未接种儿童比较,接种者临床症状比例和住院风险更低(OR=4.8,95%CI 1.12-20.2)。
- 1剂麻疹疫苗对住院的疫苗有效性估计为79%。
关键数值与推荐
- 疫苗接种状态按年龄组分析,12月龄以下婴儿(n=425)被排除。
- 1-5岁儿童(n=785)和6-17岁儿童(n=572)分别预期接种1剂和2剂麻疹疫苗。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In 2018-2019, a measles outbreak emerged in Israel (4158 notified cases). We aimed to evaluate the measles characteristics and the vaccination status among children during the outbreak. METHODS: We performed a cross-sectional study of measles cases in children under 18 years, residing in the Jerusalem district (2254 notified measles cases, June 2018-May 2019). The variables included: clinical symptoms (fever, rash, cough, coryza, conjunctivitis), hospitalizations and child's vaccination status. The national measles vaccination schedule includes two vaccine doses (at ages 12 months and 6 years). RESULTS: Children, under 18 years, comprised 79% (1782/2254) of the notified measles cases. The hospitalization rate was 6.6%. There was one fatality. The measles vaccination status was analyzed by age groups. Infants under 12 months (n = 425) were excluded. Children aged 1-5 years (n = 785) and 6-17 years (n = 572) were expected to receive 1 and 2 measles vaccine doses, respectively. Most (88%) children (1-17 years) were unvaccinated, 138 received 1 measles vaccine dose and 24 received 2 doses. Of children aged 1-5 years 106 (13.5%) received 1 vaccine dose and were compared to unvaccinated children. Vaccinated children showed lower rates of clinical symptoms and lower risk for hospitalization compared to unvaccinated children (Odds ratio: OR = 4.8, 95%CI 1.12-20.2). Vaccine effectiveness of 79% was estimated for one measles vaccine dose against hospitalization. CONCLUSIONS: Data on vaccine effectiveness reflect how well vaccines protect children against infection and morbidity. We evaluated the real-world effectiveness of measles vaccine, in an outbreak setting, and showed reduced morbidity in once-vaccinated children.
引用
- Stein-Zamir C, Shoob H, Abramson D, et al. Measles clinical presentation, hospitalization and vaccination status among children in a community-wide outbreak. Vaccine. 2023. PMID: 37002179. doi:10.1016/j.vaccine.2023.03.043
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。